Latest Breaking News On - Roche diagnostics - Page 17 : comparemela.com

<p>The Global Alzheimer&rsquo;s Platform Foundation<em>^&reg;</em>, (GAP) is releasing the first results from the Bio-Hermes-001 Study. This study in over 1000 community-based participants from throughout the US compared the results of blood and digital biomarkers with brain amyloid PET scans or cerebrospinal fluid assays. The study<em> </em>revealed a strong correlation between several blood tests, particularly p-tau 217, with the presence of amyloid plaques in the brain, a diagnostic hallmark of Alzheimer&rsquo;s disease (AD). This relationship was demonstrated across the entire study population including the 24% percent of Bio-Hermes participants from African American, Latino and other traditionally underrepresented communities, an unprecedented level of diversity. These findings will enhance the field&rsquo;s ability to provide a more economical, timely, and accurate diagnosis of Alzheimer&rsquo;s disease and s

District of columbiaUnited statesJennifer gaudiosoDianar kerwinLynn hughesJason borkTamiko magee rodgersCyndyb cordellDouglas beauregardJohn dwyerEli lillyRichardc mohsRichard mohsBio hermes collaborative groupGlobal alzheimer platform foundationJournal of the alzheimer association